Immune and Chemoprophylaxis in Hansen’s Disease
- 1 September 2023
- book chapter
- Published by Springer Nature
- p. 275-280
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Negligible risk of inducing resistance in Mycobacterium tuberculosis with single-dose rifampicin as post-exposure prophylaxis for leprosyInfectious Diseases of Poverty, 2016
- CHEMOPROPHYLAXIS TO CONTROL LEPROSY AND THE PERSPECTIVE OF ITS IMPLEMENTATION IN BRAZIL: A PRIMER FOR NON-EPIDEMIOLOGISTSRevista do Instituto de Medicina Tropical de São Paulo, 2015
- Protecting people against leprosy: Chemoprophylaxis and immunoprophylaxisClinics in Dermatology, 2015
- Leprosy and the rhetoric of eliminationBMJ, 2013
- The combined effect of chemoprophylaxis with single dose rifampicin and immunoprophylaxis with BCG to prevent leprosy in contacts of newly diagnosed leprosy cases: a cluster randomized controlled trial (MALTALEP study)BMC Infectious Diseases, 2013
- Protective effect of the combination BCG vaccination and rifampicin prophylaxis in leprosy preventionVaccine, 2009
- Effectiveness of single dose rifampicin in preventing leprosy in close contacts of patients with newly diagnosed leprosy: cluster randomised controlled trialBMJ, 2008
- Physical Distance, Genetic Relationship, Age, and Leprosy Classification Are Independent Risk Factors for Leprosy in Contacts of Patients with LeprosyThe Journal of Infectious Diseases, 2006
- PREVENTION OF LEPROSY USING RIFAMPICIN AS CHEMOPROPHYLAXISThe American Journal of Tropical Medicine and Hygiene, 2005
- Chemoprophylaxis is Effective in the Prevention of Leprosy in Endemic Countries: a Systematic Review and Meta-AnalysisJournal of Infection, 2000